Your browser doesn't support javascript.
loading
Developing a platform for secretion of biomolecules in Mycoplasma feriruminatoris.
Gonzalez-de-Miguel, Javier; Montero-Blay, Ariadna; Ciampi, Ludovica; Rodriguez-Arce, Irene; Serrano, Luis.
Afiliación
  • Gonzalez-de-Miguel J; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr Aiguader 88, Barcelona, 08003, Spain.
  • Montero-Blay A; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr Aiguader 88, Barcelona, 08003, Spain.
  • Ciampi L; Orikine Bio, Dr Aiguader 88, Barcelona, 08003, Spain.
  • Rodriguez-Arce I; Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr Aiguader 88, Barcelona, 08003, Spain.
  • Serrano L; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Microb Cell Fact ; 23(1): 124, 2024 Apr 30.
Article en En | MEDLINE | ID: mdl-38689251
ABSTRACT

BACKGROUND:

Having a simple and fast dividing organism capable of producing and exposing at its surface or secreting functional complex biomolecules with disulphide bridges is of great interest. The mycoplasma bacterial genus offers a set of relevant properties that make it an interesting chassis for such purposes, the main one being the absence of a cell wall. However, due to their slow growth, they have rarely been considered as a potential platform in this respect. This notion may be challenged with the recent discovery of Mycoplasma feriruminatoris, a species with a dividing time close to that of common microbial workhorses. So far, no tools for heterologous protein expression nor secretion have been described for it.

RESULTS:

The work presented here develops the fast-dividing M. feriruminatoris as a tool for secreting functional biomolecules of therapeutic interest that could be used for screening functional mutants as well as potentially for protein-protein interactions. Based on RNAseq, quantitative proteomics and promoter sequence comparison we have rationally designed optimal promoter sequences. Then, using in silico analysis, we have identified putative secretion signals that we validated using a luminescent reporter. The potential of the resulting secretion cassette has been shown with set of active clinically relevant proteins (interleukins and nanobodies).

CONCLUSIONS:

We have engineered Mycoplasma feriruminatoris for producing and secreting functional proteins of medical interest.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Mycoplasma Idioma: En Revista: Microb Cell Fact Asunto de la revista: BIOTECNOLOGIA / MICROBIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Mycoplasma Idioma: En Revista: Microb Cell Fact Asunto de la revista: BIOTECNOLOGIA / MICROBIOLOGIA Año: 2024 Tipo del documento: Article